Kelyniam Announces Record Net Income and Additions to the Board of Directors
03 juin 2014 09h48 HE
|
Kelyniam Global Inc.
Canton, CT, June 3, 2014 (GLOBE NEWSWIRE) -- Kelyniam Global Inc, (OTC: KLYG), a prominent manufacturer of
custom cranial implants, today reported that the company generated
net income of $71,205 in...
Kelyniam Global Inc. Revenues Grow 54% from Prior Year
07 avr. 2014 08h30 HE
|
Kelyniam Global Inc.
Canton, CT, April 7, 2014 (GLOBE NEWSWIRE) -- Kelyniam Global Inc.(OTC: KLYG), a manufacturer of custom
cranial implants, announces preliminary revenue of $1,857,516 for
2013. This represents an...
Kelyniam Global Inc. Unveils New Product
02 avr. 2014 07h20 HE
|
Kelyniam Global Inc.
Canton, CT, April 2, 2014 (GLOBE NEWSWIRE) -- Kelyniam Global Inc. has introduced a new product to the
marketplace, the "IFS"
(Integrated Fixation System) product. The product is patent
pending...
Kelyniam Global Inc. Reports Settlement of Lawsuit
05 nov. 2013 07h13 HE
|
Kelyniam Global Inc.
Canton, CT, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Kelyniam Global Inc. (OTC: KLYG) has successfully resolved the
lawsuit with former employee John Mastoloni. Per terms of the
settlement agreement,...
Kelyniam Global Inc. turns profitable during the second quarter of 2013
25 sept. 2013 08h37 HE
|
Kelyniam Global Inc.
Canton, CT, Sept. 25, 2013 (GLOBE NEWSWIRE) -- Kelyniam Global Inc. (OTC: KLYG) ("the company") is pleased to
announce that it has posted its first ever quarterly profit, for
the quarter ending June...
Kelyniam Global Inc. Announces Continued Revenue Growth & Approval to Sell Overseas
30 mai 2013 09h25 HE
|
Kelyniam Global Inc.
Canton, CT, May 30, 2013 (GLOBE NEWSWIRE) -- Kelyniam Global Inc. (OTC: KLYG), a growing
company that designs, manufactures, and sells custom
cranial/craniofacial implants, announced today its...
Kelyniam Custom Cranial Implants Receive Endorsement From Skull Based Neurosurgeon Dr. Ammirati of The Ohio State University Wexner Medical Center
29 janv. 2013 09h00 HE
|
Kelyniam Global Inc.
Canton, CT, Jan. 29, 2013 (GLOBE NEWSWIRE) -- (OTC: KLYG) Kelyniam Custom Cranial Implants, designed to fill
the boney void in a patient's skull, have been endorsed by Mario
Ammirati, MD, Director of...
Kelyniam Global Inc. Announces Record Revenues
15 janv. 2013 08h15 HE
|
Kelyniam Global Inc.
Canton, CT, Jan. 15, 2013 (GLOBE NEWSWIRE) --
Third Quarter
Kelyniam is pleased to announce record quarterly revenues of
$382,177 for the third quarter ending September 30th
2012. This...
Kelyniam Global Inc. Announces Second Quarter 2012 Revenues
15 oct. 2012 09h29 HE
|
Kelyniam Global Inc.
Canton, CT, Oct. 15, 2012 (GLOBE NEWSWIRE) -- Second Quarter Results
Kelyniam Global Inc. (OTC: KLYG) For the quarter ending June
30th 2012 Kelyniam Global Inc. reported a loss of
$45,692...
Updated - Kelyniam Receives 510k approval for Custom Craniofacial Implants
15 oct. 2012 09h25 HE
|
Kelyniam Global Inc.
Canton, CT, Oct. 15, 2012 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), today announced that the U.S.
Food and Drug Administration (FDA) has granted the company
authorization to market Custom...